Lok Sabha
A suggestion for cost audit under section 233 (B) of the Companies
Act, 1956, of companies engaged in drug manufacturing in the organized sector but not presently covered under Cost Audit orders, is under consideration of the Government.
The exercise of statutory powers under the Companies Act, in relation to any company, is subject to satisfaction of various statutory requirements laid down therein. As such no time frame can be indicated for all the companies under consideration.
This information was given by Shri Prem Chand Gupta, Minister of Company Affairs in reply to a question raised by Shri Anirudh Prasad Alias – Sadhu Yadav and Shri Kunwar Manvendra Singh in Lok Sabha today.
BY/AN
(Release ID :13793)